IGF1R and neoplasm: It has been shown that R1507, a monoclonal antibody targeting the human IGF-1R, results in the inhibition of the proliferation of several cancers, such as lung, breast, prostate cancers, and postpones the growth of xenograft tumor in nude mice [12].